<Suppliers Price>

2-Aminobenzimidazole

Names

[ CAS No. ]:
934-32-7

[ Name ]:
2-Aminobenzimidazole

[Synonym ]:
usafek-4037
2H-Benzimidazol-2-imine, 1,3-dihydro-
2-aMinobenziMidazde
2-BENZIMIDAZOLAMINE
1,3-Dihydro-2H-benzimidazol-2-imine
UNII-E65DE7521V
2-amino-1H-benzimidazole
MFCD00005596
2-amino-benzimidazol
2-Aminobenzimidazole
EINECS 213-280-6
2-amino-benzimidazole
BenziMidazoloniMide
1H-Benzimidazol-2-amine
benzimidazole-amine
2-BENZIMIDAZOLYLAMINE
AMINO-2-BENZIMIDAZOLE
2-Iminobenzimidazoline
Rabeprazole Impurity 19

Chemical & Physical Properties

[ Density]:
1.4±0.1 g/cm3

[ Boiling Point ]:
368.9±25.0 °C at 760 mmHg

[ Melting Point ]:
226-230 °C(lit.)

[ Molecular Formula ]:
C7H7N3

[ Molecular Weight ]:
133.151

[ Flash Point ]:
204.6±10.4 °C

[ Exact Mass ]:
133.063995

[ PSA ]:
54.70000

[ LogP ]:
0.78

[ Vapour Pressure ]:
0.0±0.8 mmHg at 25°C

[ Index of Refraction ]:
1.780

MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
DD5775000
CHEMICAL NAME :
Benzimidazole, 2-amino-
CAS REGISTRY NUMBER :
934-32-7
BEILSTEIN REFERENCE NO. :
0116525
LAST UPDATED :
199701
DATA ITEMS CITED :
9
MOLECULAR FORMULA :
C7-H7-N3
MOLECULAR WEIGHT :
133.17
WISWESSER LINE NOTATION :
T56 BM DNJ CZ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD40 - Lethal Dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
600 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
100 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
126 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
426 mg/kg
SEX/DURATION :
female 8-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetal death

MUTATION DATA

TYPE OF TEST :
DNA repair
TEST SYSTEM :
Bacteria - Escherichia coli
DOSE/DURATION :
2 mg/disc
REFERENCE :
JPFCD2 Journal of Environmental Science and Health, Part B: Pesticides, Food Contaminants, and Agricultural Wastes. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.B11- 1976- Volume(issue)/page/year: 21,319,1986

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H302-H315-H317-H319-H335

[ Precautionary Statements ]:
P261-P280-P305 + P351 + P338

[ Personal Protective Equipment ]:
dust mask type N95 (US);Eyeshields;Faceshields;Gloves

[ Hazard Codes ]:
Xn:Harmful;

[ Risk Phrases ]:
R22;R36/37/38

[ Safety Phrases ]:
S26-S36/37/39-S22

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3

[ RTECS ]:
DD5775000

[ HS Code ]:
29339990

Synthetic Route

Precursor & DownStream

Customs

[ HS Code ]: 2933990090

[ Summary ]:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Articles

Aggregation of 2-aminobenzimidazole--a combined experimental and theoretical investigation.

ChemPhysChem 12(9) , 1747-55, (2011)

An investigation of 2-aminobenzimidazole was carried out by calculations at HF, MP2, and DFT levels of theory and also by UV and IR spectroscopy. The quantum chemical calculations predict a full shift...

Brain-penetrating 2-aminobenzimidazole H(1)-antihistamines for the treatment of insomnia.

Bioorg. Med. Chem. Lett. 19(15) , 4380-4, (2009)

The benzimidazole core of the selective non-brain-penetrating H(1)-antihistamine mizolastine was used to identify a series of brain-penetrating H(1)-antihistamines for the potential treatment of insom...

Chemical biology strategy reveals pathway-selective inhibitor of NF-kappaB activation induced by protein kinase C.

ACS Chem. Biol. 5 , 287-299, (2010)

Dysregulation of NF-kappaB activity contributes to many autoimmune and inflammatory diseases. At least nine pathways for NF-kappaB activation have been identified, most of which converge on the Ikappa...


More Articles


Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.